Hematologic issues in the geriatric surgical patient

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Geriatric patients are at higher risk for hemorrhagic complications after surgery and traumatic injuries. The geriatric population is more likely to take anticoagulant or antiplatelet medications. Chronic disease, autoimmune disease, and nutritional deficiencies can lead to coagulation factor and platelet disorders. One must be familiar with the current anticoagulant and antiplatelet medications, their mechanism of action, and reversal agents to properly care for this group of patients. The new oral anticoagulants do not have Food and Drug Administration (FDA) approved reversal agents, but known procoagulant agents with other FDA indications may be effective.

    Original languageEnglish (US)
    Pages (from-to)129-138
    Number of pages10
    JournalSurgical Clinics of North America
    Volume95
    Issue number1
    DOIs
    StatePublished - Feb 1 2015

    Fingerprint

    Geriatrics
    Anticoagulants
    United States Food and Drug Administration
    Blood Coagulation Factors
    Malnutrition
    Autoimmune Diseases
    Patient Care
    Chronic Disease
    Blood Platelets
    Wounds and Injuries
    Population

    Keywords

    • Coagulopathy
    • Elderly
    • Reversal of oral anticoagulants

    ASJC Scopus subject areas

    • Surgery
    • Medicine(all)

    Cite this

    Hematologic issues in the geriatric surgical patient. / Van, Philbert; Schreiber, Martin.

    In: Surgical Clinics of North America, Vol. 95, No. 1, 01.02.2015, p. 129-138.

    Research output: Contribution to journalArticle

    @article{aceced1ecec14732996d7ae8e445386e,
    title = "Hematologic issues in the geriatric surgical patient",
    abstract = "Geriatric patients are at higher risk for hemorrhagic complications after surgery and traumatic injuries. The geriatric population is more likely to take anticoagulant or antiplatelet medications. Chronic disease, autoimmune disease, and nutritional deficiencies can lead to coagulation factor and platelet disorders. One must be familiar with the current anticoagulant and antiplatelet medications, their mechanism of action, and reversal agents to properly care for this group of patients. The new oral anticoagulants do not have Food and Drug Administration (FDA) approved reversal agents, but known procoagulant agents with other FDA indications may be effective.",
    keywords = "Coagulopathy, Elderly, Reversal of oral anticoagulants",
    author = "Philbert Van and Martin Schreiber",
    year = "2015",
    month = "2",
    day = "1",
    doi = "10.1016/j.suc.2014.09.012",
    language = "English (US)",
    volume = "95",
    pages = "129--138",
    journal = "Surgical Clinics of North America",
    issn = "0039-6109",
    publisher = "W.B. Saunders Ltd",
    number = "1",

    }

    TY - JOUR

    T1 - Hematologic issues in the geriatric surgical patient

    AU - Van, Philbert

    AU - Schreiber, Martin

    PY - 2015/2/1

    Y1 - 2015/2/1

    N2 - Geriatric patients are at higher risk for hemorrhagic complications after surgery and traumatic injuries. The geriatric population is more likely to take anticoagulant or antiplatelet medications. Chronic disease, autoimmune disease, and nutritional deficiencies can lead to coagulation factor and platelet disorders. One must be familiar with the current anticoagulant and antiplatelet medications, their mechanism of action, and reversal agents to properly care for this group of patients. The new oral anticoagulants do not have Food and Drug Administration (FDA) approved reversal agents, but known procoagulant agents with other FDA indications may be effective.

    AB - Geriatric patients are at higher risk for hemorrhagic complications after surgery and traumatic injuries. The geriatric population is more likely to take anticoagulant or antiplatelet medications. Chronic disease, autoimmune disease, and nutritional deficiencies can lead to coagulation factor and platelet disorders. One must be familiar with the current anticoagulant and antiplatelet medications, their mechanism of action, and reversal agents to properly care for this group of patients. The new oral anticoagulants do not have Food and Drug Administration (FDA) approved reversal agents, but known procoagulant agents with other FDA indications may be effective.

    KW - Coagulopathy

    KW - Elderly

    KW - Reversal of oral anticoagulants

    UR - http://www.scopus.com/inward/record.url?scp=84912529395&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84912529395&partnerID=8YFLogxK

    U2 - 10.1016/j.suc.2014.09.012

    DO - 10.1016/j.suc.2014.09.012

    M3 - Article

    C2 - 25459547

    AN - SCOPUS:84912529395

    VL - 95

    SP - 129

    EP - 138

    JO - Surgical Clinics of North America

    JF - Surgical Clinics of North America

    SN - 0039-6109

    IS - 1

    ER -